中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:( Pengbo ZHU)

1.Analysis of X-ray Signs of Multiple Tuberculosis of Bone and Joint

Hengli ZHU ; Xiaoyan LIANG ; Pengbo HAN ; Fanli HUANG ; Minyi FAN

Journal of Practical Radiology 2001;0(07):-

2.The preliminary study on the measurement of(1,3)β-D glucan in plasma for the diagnosis of pulmonary fungal infections in pulmonary tuberculosis patients

Zuqiong HU ; Xueya LI ; Linyan HU ; Pengbo ZHU ; Zhizhong CAO ; Cairong ZOU ; Meiyu PAN

The Journal of Practical Medicine 2017;33(10):1615-1618

3.Effects of different dental implant systems on the peri-implant bone absorption

Yan ZHU ; Pengbo WAN ; Wei ZHAO ; Xiaoling WANG ; Jin LIU ; Kangkang WEI ; Junxiang LIU

Chinese Journal of Tissue Engineering Research 2016;20(30):4419-4424

4.Pregnancy outcome of monochorionic triamniotic triplet pregnancies and its relationship with multifetal pregnancy reduction

Ying ZHOU ; Yujie JIAO ; Peijing ZHU ; Pengbo YUAN ; Xueju WANG ; Xiaoli GONG ; Yangyu ZHAO ; Yuan WEI

Chinese Journal of Perinatal Medicine 2021;24(4):249-253

5.Progress of gene-mediated precision immunotherapy in the treatment of acute myeloid leukemia

Pengbo ZHAO ; Ying ZHU ; Lifang YIN ; Xiaofei XIN

Journal of China Pharmaceutical University 2024;55(1):53-62

6.Viral infection and epidemiological characteristics of human metapneumovirus in febrile respiratory syndrome cases in nine provinces in China from 2009 to 2021

Aili CUI ; Zhibo XIE ; Pengbo YU ; Runan ZHU ; Yingwei MA ; Xingyu XIANG ; Liping ZHANG ; Yun ZHU ; Julong WU ; Zhenguo GAO ; Rongbo ZHANG ; Guangyue HAN ; Wenbo XU ; Yan ZHANG

Chinese Journal of Applied Clinical Pediatrics 2021;36(24):1861-1865

7.Advances of CRISPR/Cas9 activation system.

Xiao DING ; Zhuanxia PAN ; Liuliu YANG ; Xiaoli LUO ; Nan JIANG ; Mengjie ZHU ; Cuicui WU ; Gang LAN ; Pengbo LI

Chinese Journal of Biotechnology 2022;38(8):2713-2724

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO